Modeling the impact of treatment of herpesvirus infections on costs and quality of life: based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
New England Medical Center
1995
|
| Schriftenreihe: | Pharmacotherapy
15,2 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-H. |
| Beschreibung: | 65 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011077752 | ||
| 003 | DE-604 | ||
| 005 | 19961126 | ||
| 007 | t | ||
| 008 | 961126s1995 d||| |||| 10||| eng d | ||
| 035 | |a (OCoLC)164848430 | ||
| 035 | |a (DE-599)BVBBV011077752 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Modeling the impact of treatment of herpesvirus infections on costs and quality of life |b based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 |c guest ed.: Andy Stergachis |
| 264 | 1 | |a Boston, MA |b New England Medical Center |c 1995 | |
| 300 | |a 65 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Pharmacotherapy |v 15,2 | |
| 500 | |a Einzelaufnahme eines Zeitschr.-H. | ||
| 650 | 0 | 7 | |a Herpes |0 (DE-588)4024566-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Virostatikum |0 (DE-588)4063598-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1995 |z Seattle Wash. |2 gnd-content | |
| 689 | 0 | 0 | |a Herpes |0 (DE-588)4024566-4 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | 2 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Herpes |0 (DE-588)4024566-4 |D s |
| 689 | 1 | 1 | |a Virostatikum |0 (DE-588)4063598-3 |D s |
| 689 | 1 | 2 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Stergachis, Andy |e Sonstige |4 oth | |
| 710 | 2 | |a American College of Clinical Pharmacy (Kansas City, Mo.) |e Sonstige |0 (DE-588)5143268-7 |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007421305 | ||
Datensatz im Suchindex
| _version_ | 1804125568783876096 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011077752 |
| ctrlnum | (OCoLC)164848430 (DE-599)BVBBV011077752 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01890nam a2200445 cb4500</leader><controlfield tag="001">BV011077752</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19961126 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">961126s1995 d||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)164848430</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011077752</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Modeling the impact of treatment of herpesvirus infections on costs and quality of life</subfield><subfield code="b">based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995</subfield><subfield code="c">guest ed.: Andy Stergachis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">New England Medical Center</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">65 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacotherapy</subfield><subfield code="v">15,2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-H.</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herpes</subfield><subfield code="0">(DE-588)4024566-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Virostatikum</subfield><subfield code="0">(DE-588)4063598-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1995</subfield><subfield code="z">Seattle Wash.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Herpes</subfield><subfield code="0">(DE-588)4024566-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Herpes</subfield><subfield code="0">(DE-588)4024566-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Virostatikum</subfield><subfield code="0">(DE-588)4063598-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stergachis, Andy</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">American College of Clinical Pharmacy (Kansas City, Mo.)</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5143268-7</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007421305</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1995 Seattle Wash. gnd-content |
| genre_facet | Konferenzschrift 1995 Seattle Wash. |
| id | DE-604.BV011077752 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:03:38Z |
| institution | BVB |
| institution_GND | (DE-588)5143268-7 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007421305 |
| oclc_num | 164848430 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 65 S. graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | New England Medical Center |
| record_format | marc |
| series2 | Pharmacotherapy |
| spelling | Modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 guest ed.: Andy Stergachis Boston, MA New England Medical Center 1995 65 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmacotherapy 15,2 Einzelaufnahme eines Zeitschr.-H. Herpes (DE-588)4024566-4 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Gesundheitsökonomie (DE-588)4130935-2 gnd rswk-swf Virostatikum (DE-588)4063598-3 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1995 Seattle Wash. gnd-content Herpes (DE-588)4024566-4 s Pharmakotherapie (DE-588)4076066-2 s Gesundheitsökonomie (DE-588)4130935-2 s DE-604 Virostatikum (DE-588)4063598-3 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s Stergachis, Andy Sonstige oth American College of Clinical Pharmacy (Kansas City, Mo.) Sonstige (DE-588)5143268-7 oth |
| spellingShingle | Modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 Herpes (DE-588)4024566-4 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Virostatikum (DE-588)4063598-3 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4024566-4 (DE-588)4032589-1 (DE-588)4130935-2 (DE-588)4063598-3 (DE-588)4076066-2 (DE-588)1071861417 |
| title | Modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 |
| title_auth | Modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 |
| title_exact_search | Modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 |
| title_full | Modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 guest ed.: Andy Stergachis |
| title_fullStr | Modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 guest ed.: Andy Stergachis |
| title_full_unstemmed | Modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 guest ed.: Andy Stergachis |
| title_short | Modeling the impact of treatment of herpesvirus infections on costs and quality of life |
| title_sort | modeling the impact of treatment of herpesvirus infections on costs and quality of life based on proceedings of an industry classroom during the 1995 winter practice and research forum of the american college of clinical pharmacy orlando florida february 14 1995 |
| title_sub | based on proceedings of an industry classroom during the 1995 Winter Practice and Research Forum of the American College of Clinical Pharmacy, Orlando, Florida, February 14, 1995 |
| topic | Herpes (DE-588)4024566-4 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd Virostatikum (DE-588)4063598-3 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | Herpes Kosten-Nutzen-Analyse Gesundheitsökonomie Virostatikum Pharmakotherapie Konferenzschrift 1995 Seattle Wash. |
| work_keys_str_mv | AT stergachisandy modelingtheimpactoftreatmentofherpesvirusinfectionsoncostsandqualityoflifebasedonproceedingsofanindustryclassroomduringthe1995winterpracticeandresearchforumoftheamericancollegeofclinicalpharmacyorlandofloridafebruary141995 AT americancollegeofclinicalpharmacykansascitymo modelingtheimpactoftreatmentofherpesvirusinfectionsoncostsandqualityoflifebasedonproceedingsofanindustryclassroomduringthe1995winterpracticeandresearchforumoftheamericancollegeofclinicalpharmacyorlandofloridafebruary141995 |